Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?
Cancer Treatment Reviews · 2023
DOI: 10.1016/j.ctrv.2023.102585 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2023. Verfasst von Robert I Haddad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Robert_Haddad@dfc…. Hauptthemen laut MEDLINE: Cisplatin, Head and Neck Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Robert_Haddad@dfci.harvard.edu.
- The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Kevin.Harrington@icr.ac.uk.
- National Cancer Center Hospital East, Kashiwa, Chiba Prefecture, Japan. Electronic address: matahara@east.ncc.go.jp.
- Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Lausanne, Switzerland. Electronic address: szturz@gmail.com.
- Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris, France. Electronic address: christophe.letourneau@curie.fr.
- Merck Healthcare KGaA, Darmstadt, Germany. Electronic address: satu.salmio@merckgroup.com.
Zitieren
APA
Haddad, R. I., Harrington, K., Tahara, M., Szturz, P., Le Tourneau, C., Salmio, S., Bajars, M., & Lee, N. Y. (2023). Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2023.102585
Vancouver
Haddad RI, Harrington K, Tahara M, Szturz P, Le Tourneau C, Salmio S, et al. Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?. Cancer Treatment Reviews. 2023. doi:10.1016/j.ctrv.2023.102585
BibTeX
@article{Haddad2023,
author = {Haddad, Robert I and Harrington, Kevin and Tahara, Makoto and Szturz, Petr and Le Tourneau, Christophe and Salmio, Satu and Bajars, Marcis and Lee, Nancy Y},
title = {Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?},
journal = {Cancer Treatment Reviews},
year = {2023},
doi = {10.1016/j.ctrv.2023.102585}
}
EUVIMED